Stockscreener 앱 받기
5.80
1.58%
0.09
시간 외 거래:
5.80
Verrica Pharmaceuticals Inc (VRCA) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
12.93%
14.34
|
12.70 | 3.439 | 0.344 | -1.781 |
Operating Expenses
|
13.63%
12.72
|
11.19 | 11.57 | 11.75 | 18.92 |
| Benefits Costs and Expenses |
-
|
- | 13.18 | 16.55 | - |
| Costs And Expenses |
13.63%
12.72
|
11.19 | 13.18 | 16.55 | 18.92 |
| Operating Income/Loss |
7.75%
1.627
|
1.51 | -8.13 | -11.41 | -20.70 |
| Nonoperating Income/Loss |
45.56%
-1.901
|
-1.306 | -1.612 | -4.792 | -2.156 |
| Income/Loss From Continuing Operations Before Tax |
6,931%
14.34
|
0.204 | -9.742 | -16.20 | -1.781 |
| Income/Loss From Continuing Operations After Tax |
234.31%
-0.274
|
0.204 | -9.742 | -16.20 | -22.86 |
|
Net Income/Loss
|
234.31%
-0.274
|
0.204 | -9.742 | -16.20 | -22.86 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.02%
9.4901
|
9.4881 | 94.84 | 5.2103 | 46.81 |
| Diluted Average Shares |
0.01%
9.4901
|
9.4906 | 94.84 | 5.2103 | 46.81 |
| Basic Earnings Per Share |
250.00%
-0.03
|
0.02 | -0.10 | -0.18 | -0.49 |
| Diluted Earnings Per Share |
250.00%
-0.03
|
0.02 | -0.10 | -0.18 | -0.49 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.20%
0.06%
자본화:
|
볼륨(24시간):